U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07737236) titled 'Ruscus Evaluation for Symptom Control in Uncomplicated Chronic Venous Insufficiency' on July 27.

Brief Summary: This multicenter, prospective, observational study aims to generate and analyze real-world data on the effectiveness and safety of Ruscus aculeatus L. treatment in patients with symptomatic chronic venous disease classified as CEAP C1-C6. Patients receiving Ruscus aculeatus L. as part of routine clinical practice will be followed for 90 days without any study-mandated intervention. Disease severity will be assessed using the revised Venous Clinical Severity Score (rVCSS), pain using the Visual Analog Scale (VAS), quality o...